Related Experiment Video
Updated: Jun 11, 2026

10:17
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Artificial intelligence for right ventricular assessment: current evidence and future directions.
Xin Tan1, Jarrett Fowler2, Meng Li1,3
1Department of Statistics, Rice University.
Current Opinion in Cardiology
|June 10, 2026
Summary
Artificial intelligence (AI) can accurately assess right ventricular (RV) structure and function using cardiac imaging, improving consistency in measurements. Further validation is needed for widespread clinical adoption of AI in cardiology.
Area of Science:
- Cardiology
- Medical Imaging
- Artificial Intelligence
Background:
- Right ventricular (RV) assessment is crucial for risk stratification in various heart conditions.
- Current RV assessment methods are technically challenging and prone to variability.
- Artificial intelligence (AI) offers potential solutions for automated RV analysis.
Purpose of the Study:
- To review the emerging applications of AI in assessing RV structure and function.
- To synthesize evidence across echocardiography, cardiac magnetic resonance (CMR), and computed tomography.
- To evaluate AI's accuracy and potential in RV quantification and functional assessment.
Main Methods:
- Systematic review of recent literature on AI in RV assessment.
- Analysis of AI performance in segmentation, chamber quantification, and functional parameter estimation.
- Comparison of AI-derived metrics against established imaging modalities, particularly CMR.
Main Results:
- AI demonstrates high accuracy for automated RV segmentation and quantification, comparable to interobserver variability.
- AI accurately estimates functional parameters like fractional area change and ejection fraction.
- Emerging AI applications focus on RV-pulmonary artery coupling and hemodynamic phenotyping.
Conclusions:
- AI tools can standardize and expedite RV measurements, especially in echocardiography.
- Clinical translation requires external validation across diverse disease phenotypes.
- Future implementation necessitates hybrid AI workflows and studies demonstrating clinical impact.